DDB1 Antibody [M17E15]

Catalog No.: F5000

Application: Reactivity: Human, Mouse, Rat, Monkey

Lane 1: Hela, Lane 2: 3T3, Lane 3: PC-12, Lane 4: COS-7

当該製品は品切れ状态で、ごメールアドレスを教えていただければ、在庫があると、メールで顧客様に伝えます。

代表番号: 045-509-1970|電子メール：sales@selleck.co.jp

使用情報

Dilution
WB1:1000

Application
WB

Source
Rabbit Monoclonal Antibody

Reactivity
Human, Mouse, Rat, Monkey

Storage Buffer
PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3

Storage (from the date of receipt)
-20°C (avoid freeze-thaw cycles), 2 years

Predicted MW
127 kDa

Datasheet & SDS

生物学的記述

Specificity
DDB1 Antibody [M17E15] detects endogenous levels of total DDB1 protein.

Clone
M17E15

Synonym(s)
DNA damage-binding protein 1; DDB p127 subunit; DNA damage-binding protein a (DDBa); XAP-1; UV-DDB 1; XPE-binding factor (XPE-BF); Xeroderma pigmentosum group E-complementing protein (XPCe); DDB1; XAP1

Background
DDB1 (damage-specific DNA binding protein 1), the scaffold subunit of the CRL4 ubiquitin E3 ligase family, orchestrates nucleotide excision repair initiation, histone eviction, and cell cycle checkpoint enforcement by recruiting diverse substrate receptors to damaged chromatin sites. Its propeller blade architecture with a central β-sheet core accommodates the DDB2 WD40 domain for lesion-specific recognition of cyclobutane pyrimidine dimers and 6-4 photoproducts, while the lateral surface docks CUL4A-ROC1 to catalyze K48/K63-linked polyubiquitination of repair factors like XPC, DDB2 itself, and histones H3/H4. Upon UV exposure, DDB1 translocates from soluble to tightly chromatin-bound fractions in a DDB2-dependent manner, facilitating ubiquitination-mediated displacement of core histones to expose lesions for XPC loading and TFIIH recruitment; this histone code handover licenses dual incision while preventing error-prone repair. DDB1 scaffolds additional DCAFs like VprBP for HIV integration and CDT1 for replication licensing, integrating DNA damage with G1/S transition via p21/p27 degradation. DDB1 maintains genomic stability across proliferating tissues, with acute depletion triggering p53-dependent apoptosis in neural progenitors and hematopoietic stem cells through unresolved replication stress. Mutations underlie xeroderma pigmentosum E through defective UV-DDB assembly, while CUL4-DDB1 overexpression drives tumorigenesis via CDT1 hyperdegradation and replication origin firing.

Background

DDB1 (damage-specific DNA binding protein 1), the scaffold subunit of the CRL4 ubiquitin E3 ligase family, orchestrates nucleotide excision repair initiation, histone eviction, and cell cycle checkpoint enforcement by recruiting diverse substrate receptors to damaged chromatin sites. Its propeller blade architecture with a central β-sheet core accommodates the DDB2 WD40 domain for lesion-specific recognition of cyclobutane pyrimidine dimers and 6-4 photoproducts, while the lateral surface docks CUL4A-ROC1 to catalyze K48/K63-linked polyubiquitination of repair factors like XPC, DDB2 itself, and histones H3/H4. Upon UV exposure, DDB1 translocates from soluble to tightly chromatin-bound fractions in a DDB2-dependent manner, facilitating ubiquitination-mediated displacement of core histones to expose lesions for XPC loading and TFIIH recruitment; this histone code handover licenses dual incision while preventing error-prone repair. DDB1 scaffolds additional DCAFs like VprBP for HIV integration and CDT1 for replication licensing, integrating DNA damage with G1/S transition via p21/p27 degradation. DDB1 maintains genomic stability across proliferating tissues, with acute depletion triggering p53-dependent apoptosis in neural progenitors and hematopoietic stem cells through unresolved replication stress. Mutations underlie xeroderma pigmentosum E through defective UV-DDB assembly, while CUL4-DDB1 overexpression drives tumorigenesis via CDT1 hyperdegradation and replication origin firing.

References
[1] Li J, et al. Cancer Res. 2006 Sep 1;66(17):8590-7. [2] Liu L, et al. Mol Cell. 2009 May 14;34(4):451-60.

PVDFメンブレン孔径参考表

Protein Size (kDa)	PVDF Transfer Membrane Pore Size (μm)
< 10	0.22
10-20	0.22
20-30	0.45
30-45	0.45
45-70	0.45
80-100	0.45
100-140	0.45
> 140	0.45

技術サポート

ストックの作り方、阻害剤の保管方法、細胞実験や動物実験の際に注意すべき点など、製品を取扱う時に問い合わせが多かった質問に対しては取扱説明書でお答えしています。

Handling Instructions

他に質問がある場合は、お気軽にお問い合わせください。

* 必須

* 大学・企業名 大学・企業名を記入してください

* 名前 名前を記入してください

* 電子メール 電子メール・アドレスを記入してください 有効なメールアドレスを入力してください

電話番号

* 内容 お問い合わせ内容をご入力ください

Protein Size (kDa)	Separating Gel Percentage
4-40	20%
12-45	15%
10-70	12.5%
15-100	10%
25-100	8%
60-210	5%